Federal Judge Certifies Shareholder Class In Suit Against Pharma Company

Mealey's (February 25, 2016, 1:56 PM EST) -- NEWARK, N.J. — A federal judge in New Jersey on Feb. 22 granted a motion for class certification in a securities lawsuit against a pharmaceutical company and others alleged to have issued misstatements in the offering documents for the company’s initial public offering (IPO), ruling that the lead plaintiffs properly met all statutory requirements to certify the class (Robin J. Dartell, et al. v. Tibet Pharmaceuticals Inc., et al., No. 14-3620, D. N.J.; 2016 U.S. Dist. LEXIS 21541).

(Opinion available. Document #57-160321-020Z.)

Lead plaintiffs Obasi Investment...
To view the full article, register now.